BackAkebia Therapeutics Overview
Akebia Therapeutics Inc.

Akebia Therapeutics Target Price

Analysts' 12-month price predictions for AKBA.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.24

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-02-06Piper SandlerAllison Bratzel$4222.6% upsideOpen
2024-03-28H.C. WainwrightEd Arce$6383.9% upsideOpen
2022-03-03NeedhamSerge Belanger$7464.5% upsideOpen